Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

Shoppers Stop - Focusing on omni-channel growth - ICICI Securities

Posted On: 2021-01-19 05:09:39 (Time Zone: Arizona, USA)


Key takeaways from Shoppers Stop's (SHOP) Q3FY21 result: a) Standalone revenue (non-GAAP) declined 32% YoY to Rs8.9bn with EBITDA of Rs210mn; b) management remains cautiously optimistic on demand recovery and expects normalcy by Q2FY22; c) SHOP aims to add 10-12 department stores and close 5-7 unprofitable stores in FY22; d) online sales increased 3x YoY and contributed 6% of sales in Q3FY21; expect omni-channel to contribute ~15% of revenue over the next 3-4 years, and e) SHOP has net cash of Rs460mn as of Dec'20, post rights issue of Rs3bn at Rs140/sh. Maintain BUY with a revised DCF-based target price of Rs235/share (earlier: Rs222) on roll over to FY23E (earlier: Sep'22E). Key risks being slower recovery in discretionary spends and increasing online competition.

- Management remains cautiously optimistic on demand recovery and expects normalcy by Q2FY22. Continued lockdown relaxations and festive season restricted footfalls decline to 50% YoY in Q3FY21 vs 81% in Q2FY21. East region performed relatively better than other regions, while Delhi NCR was impacted in Dec'20 due to local unrest. Tier-2&3 towns continued to outperform metro cities as metro stores' revenue declined 39% YoY, while non-metro revenue fell 23% YoY. Conversions increased 700bps YoY. Gross margin (non-GAAP) reduced 120bps YoY to 32.0% owing to Rs30mn inventory provision and higher discounting on private labels.

- On track to achieve cost savings of Rs4.5bn in FY21E (already achieved Rs3.9bn in 9MFY21 and Rs750mn in Q3FY21). Management expects sustainable cost savings of Rs2bn in coming years. SHOP raised Rs3bn via rights issue at Rs140/sh and has net cash of Rs460mn as of Dec'20.

- Improvement in key strategic pillars: 'First Citizen' (FC) customers contributed 83% to sales (+2.2% YoY) and SHOP has added 309k customers in Q3FY21 taking the total count to 7.7mn as of Dec'20. 'Personal Shoppers' accounted 16% (+2.2% YoY) of sales while private labels' share rose 220bps YoY to 13.4% of sales with increased products offerings such as sleepwear, loungewear and innerwear categories. Beauty portfolio contributed 15.7% to sales, while Arcelia private label was launched in 63 stores in Bath & Body category. Online sales grew strong at 3x YoY and contributed ~6% of total revenue in Q3FY21. Management is targeting omni-channel to increase its contribution to ~15% of sales over the next 3-4 years.

- Management expects to open 10-12 department stores (with an average size of 20-30k sq ft) and close 5-7 unprofitable stores in FY22. Besides, SHOP is targeting to open 3-5 Arcelia beauty stores in FY22. SHOP closed (on net basis) one department store during the quarter taking total department store count to 84, of which 73 are mall stores. It closed one airport store, one beauty store and four Crossword stores during the quarter. SHOP now has 26 airport stores, 130 beauty stores and 29 Crossword stores.

Shares of SHOPPERS STOP LTD. was last trading in BSE at Rs.209.8 as compared to the previous close of Rs. 206.2. The total number of shares traded during the day was 7741 in over 350 trades.

The stock hit an intraday high of Rs. 210.95 and intraday low of 205. The net turnover during the day was Rs. 1615978.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

Easy Trip Planners Ltd. - IPO - Strong Financials - Reliance Securities

Bharat Forge - Initiating Coverage - Constant evolution - HDFC Securities

Mahindra Logistics - Large-ticket deal win - ICICI Securities

Company Update - Huhtamaki India - ICICI Direct

Gladiator Stocks: IndusInd Bank, VIP Industries - ICICI Direct

Warehousing demand expected to grow around 160% to reach 35 million sq. ft in 2021: JLL

Telecom - Spectrum auction: Prudent investment by Bharti Airtel - ICICI Securities

JB Chemicals & Pharmaceuticals - Analyst meet takeaways - ICICI Securities

IPO Review - MTAR Technologies Ltd - ICICI Direct

Auto Sector - Monthly Volume Round-up - Feb 21 - Decent YoY Growth Continues

Aditya Birla Fashion and Retail - Focus on scaling up new businesses - ICICI Securities

Automobiles (wholesale) - Wholesales push continues despite modest retail trends - ICICI Securities

Aditya Birla Capital - Thoughtful (inclusive) conglomerate business evolution commands premium - ICICI Securities

Jubilant Foodworks - Buying in-the-money options - ICICI Securities

Multi Commodity Exchange of India - Play on rising commodity prices? - ICICI Securities

Gladiator Stocks - Sudarshan Chemical - ICICI Direct

Monthly Commodities Outlook - March 2021 - ICICI Direct

ICICI Direct - Monthly Currency Outlook: Rupee to depreciate further towards 75.00 level...

ICICI Direct - Covid Recovery Pulse - E-way bill generation in February 2021 starts on strong note...

Company Update - Virtual JLR Investor Event - Tata Motors - ICICI Direct

Analyst Meet Update - Aditya Birla Fashion and Retail - ICICI Direct

MTAR Technologies Ltd. - IPO - Huge Opportunities from Clean Energy Bodes Well - Reliance Research

ICICI Direct Derivatives Weekly View (February 26): Failure to move above 14700 may extend declines towards 14300...

Bank: Sector Credit Trends - Slows, Yet again - HDFC Securities

Piramal Enterprises - Pharma day highlights - ICICI Securities

Polymer price tracker - PVC prices rise sharply again! - ICICI Securities

Greenply Industries - Growth returns, at an inflection point - ICICI Securities

Tata Motors - JLR future proofing itself with rapid electric transition - ICICI Securities

Dairy - Higher freight cost and increase in Global SMP prices - ICICI Securities

Analyst Meet Update - Nestlé India (Hold): Focus on product innovation, expanding rural reach - ICICI Direct

MTAR Technologies Ltd - A strong player in booming high precision engineering... - Geojit

Rollover Report for February - March 2021 : Angel Broking

Reaction from industry experts on Q3FY21 GDP numbers

M. Govinda Rao, Chief Economic Adviser, Brickwork ratings on Q3FY21 GDP numbers

Mr. Dhiraj Relli, MD & CEO, HDFC securities views on Q3FY21 GDP Growth Number

Suman Chowdhury, Chief Analytical Officer, Acuité Ratings & Research on Q3FY21 GDP

Rollover Analysis - Feb 21, 2021 - YES Securities

Consumer Durables - Demand-driven recovery continues - HDFC Securities

Cement - Demand surprises; earnings upgrade to continue - ICICI Securities

Gladiator Stocks - TeamLease Services - ICICI Direct

Gladiator Stocks - Metals to outshine post multi-year breakout... - ICICI Direct

Company Update - Sundaram Finance - ICICI Direct

Indian pharmaceutical industry to meet an ambition of US$130 billion by 2030 through innovation-led growth: EY-FICCI report

4th Industrial Conclave - Bullish undertone, favourable valuation - HDFC Securities

Sanofi India - Weak quarter; sequential improvement - ICICI Securities

Sunteck Realty - All eyes on upcoming launches - ICICI Securities

Company Update - Tata Motors - ICICI Direct

Q4CY20 Company Update - Mahindra CIE Automotive - ICICI Direct

Event Update - Hindalco - ICICI Direct

EY report launch at BioAsia 2021 - Moving the needle: Healthcare industry in a post-COVID world



Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020